Welcome to the real world

pharmafile | August 21, 2008 | Feature | Research and Development |  clinical trials, design, observational, phase III 

Related Content

EMA selects TrialAssure anonymisation platform for clinical trial documents

TrialAssure has announced that its ANONYMIZE platform has been selected by the European Medicines Agency …

Vesper Bio reports positive topline results for dementia candidate

Vesper Bio, a clinical-stage biotech developing novel oral therapies for neurodegenerative and neuropsychiatric disorders, has …

Von Willebrand disease – increasing awareness and access to vital care

Pharmafile talks to Anthea Cherednichenko, Vice President Franchise Head Haematology and Transplant at Takeda about …

The Gateway to Local Adoption Series

Latest content